PreveCeutical Medical Inc., a health sciences company, develops options for preventive and curative therapies utilizing organic and nature identical products. It has research and development programs, including dual gene therapy for curative and prevention therapies for diabetes and obesity; the Program; Nature Identical peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions. The company offers CELLB9 immune system booster, an oral solution containing polarized and potentiated essential minerals extracted from a peptide obtained from Caribbean blue scorpion venom. It also provides medicinal cannabis-based products. The company has a research and option agreement with University of Queensland; and the UniQuest Pty Limited to develop non-addictive analgesics for the treatment of pain. It also has a strategic research and development supply agreement with Aurora Cannabis to produce medical cannabis. PreveCeutical Medical Inc. is based in Vancouver, Canada.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone604-416-7777
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Preveceutical Medical (CNSX:PREV) Frequently Asked Questions
What is Preveceutical Medical's stock symbol?
Preveceutical Medical trades on the CNSX under the ticker symbol "PREV."
Has Preveceutical Medical been receiving favorable news coverage?
Media headlines about PREV stock have trended negative this week, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Preveceutical Medical earned a media sentiment score of -2.0 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the company's share price in the immediate future. View News Stories for Preveceutical Medical.
Who are some of Preveceutical Medical's key competitors?
Some companies that are related to Preveceutical Medical include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Almirall (LBTSF), Apotheca Biosciences (CBDC), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Baudax Bio (BXRXV), BerGenBio ASA (BRRGF), Biocure Technology (CURE), Canada House Wellness Group (CHV), Cannabics Pharmaceuticals (CNBX), CannaRoyalty (ORHOF), Cardiome Pharma (COM) and China Longyi Group Int'l (CGYG).
What other stocks do shareholders of Preveceutical Medical own?
Who are Preveceutical Medical's key executives?
Preveceutical Medical's management team includes the folowing people:
- Mr. Stephen Van Deventer, Chairman & CEO (Age 50)
- Dr. Makarand Jawadekar Ph.D., Chief Science Officer, Pres & Director (Age 68)
- Ms. Shabira Rajan CPA, CGA, CFO & Controller (Age 63)
- Ms. Deanna Kress, Director of Corp. Communications & Investor Relations
- Ms. Alicia Rebman, Marketing Director (Age 42)
How do I buy shares of Preveceutical Medical?
Shares of PREV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Preveceutical Medical's official website?
How can I contact Preveceutical Medical?
The company can be reached via phone at 604-416-7777.
MarketBeat Community Rating for Preveceutical Medical (CNSX PREV)
MarketBeat's community ratings are surveys of what our community members think about Preveceutical Medical and other stocks. Vote "Outperform" if you believe PREV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PREV will underperform the S&P 500 over the long term. You may vote once every thirty days.
